Highlights in Lung Cancer, 2013, Part 5: Maintenance Therapy in Advanced NSCLC (video)

GRACEcast Cancer 101 Audio
07/04/2013 3 min
Highlights in Lung Cancer, 2013, Part 5: Maintenance Therapy in Advanced NSCLC (video)

Listen "Highlights in Lung Cancer, 2013, Part 5: Maintenance Therapy in Advanced NSCLC (video)"

Descargar episodio Ver en sitio original

Episode Synopsis

Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, summarizes evidence from the PARAMOUNT trial, demonstrating a survival benefit for continuation maintenance therapy with Alimta (Pemetrexed) in advanced non-small cell lung cancer.

More episodes of the podcast GRACEcast Cancer 101 Audio

Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy? 31/07/2014
Management of Rare Kidney Tumors 29/07/2014
Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation? 27/07/2014
NanoString Treatment for Kidney Cancer 24/07/2014
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer? 22/07/2014
How is the Heng Criteria Applied to Kidney Cancer Patients? 20/07/2014
Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment? 17/07/2014
What is PD1 and PDL1 in Kidney Cancer? 15/07/2014
Zykadia for ALK Positive Lung Cancer: New Drug, New Hope 13/07/2014
No Clear Answer for Non-Clear Cell Kidney Cancer 10/07/2014
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA